June 28, 2007 - Patients who receive implantable cardiac defibrillators (ICD) have a better survival rate than their counterparts who do not undergo ICD implantation, according to a study by Canadian researchers published in the June 26th issue of the Journal of the American College of Cardiology (J Am Coll Cardiol 2007;49:2408-2415).

June 28, 2007 - CryoCor Inc., a medical device company focused on the treatment of cardiac arrhythmias, announced that the FDA Advisory Panel recommended that CryoCor’s application for pre-market approval (PMA) for the treatment of atrial flutter be approved by the FDA.

The meeting of the Advisory Panel was held on June 27, 2007 and a decision from the FDA on CryoCor's PMA is expected in August 2007.

"We are pleased with the decision by the Advisory Panel to recommend our PMA for approval and look forward to the FDA’s decision in August,” said Helen Barold, M.D.

June 27, 2007 - Medtronic, Inc. announced the European launch of the Medtronic CareLink Network, a new heart monitoring system designed to enable patients at risk of heart conditions to electronically transmit data from their implanted cardiac device directly to their physician, allowing the completion of check-ups without requiring the patient to leave home.

June 27, 2007 - According to a study published in the New England Journal of Medicine, estrogen can significantly limit the accumulation of plaque in the arteries of women in their fifties.

The study involved 1,064 participants from ages 50 to 59, who had undergone surgically induced menopause through a hysterectomy. Study participants took estrogen or a placebo for 7.5 years, after which cardiac scans were performed to determine the level of plaque accumulated in their arteries.

June 27, 2007 - CMS and the Hospital Quality Alliance posted on the Hospital Compare Web site data that provide a broad comparison of mortality rates for heart attack and heart failure in hospital patients, in order to promote quality and to give consumers information for making informed decisions in healthcare.

June 22, 2007 - CardioDynamics, an impedance cardiography (ICG) technology developer, announced that it has reached an agreement to sell its Vermed unit to the subsidiary's management team for a cash purchase price of $8 million, allowing CardioDynamics to focus its resources on its proprietary ICG business, which continues to hold the highest growth potential.

June 27, 2007 — REVA Medical, Inc. recently announced enrollment of the first patients in a first-in-man clinical trial designed to evaluate the safety of the REVA Bioresorbable Coronary Stent for the treatment of coronary artery disease.

The RESORB (REVA Endovascular Study of a Bioresorbable Coronary Stent) trial will enroll up to 30 patients at multiple sites in Germany and Brazil in a non-randomized study with an initial assessment of major adverse cardiac events (MACE) at 30 days and a follow-up period of five years.

June 20, 2007 — Sono-Tek Corporation recently announced the release of the MediCoat PSI, a system which offers the same cutting-edge precision stent coating features as the well established MediCoat DES systems used for coating cardiac stents.

June 21, 2007 – MedSolutions, a radiology management services provider, introduced at AHIP 2007 Outcomes-Focused Cardiac Imaging, its cardiac imaging management product designed for managing diagnostic cardiac imaging, promoting the delivery of appropriate tests through qualified providers and reducing costs.

June 26, 2007 - Physicians who report quality measures for care delivered to Medicare beneficiaries July 1–December 31, 2007 may receive an additional 1.5 percent incentive payment, subject to a bonus payment cap.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now